Home
About
Overview
Sharing Data
ORCID
Help
History (1)
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer. Cancer Res. 2020 02 15; 80(4):732-746.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Animals
Antigen Presentation
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
B7-H1 Antigen
Cell Line, Tumor
Chemoradiotherapy
Cohort Studies
Disease Models, Animal
Down-Regulation
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Head and Neck Neoplasms
Healthy Volunteers
HEK293 Cells
Histocompatibility Antigens Class II
Human papillomavirus 16
Humans
Male
Mice
Middle Aged
Oncogene Proteins, Viral
Papillomavirus Infections
RAW 264.7 Cells
Rimantadine
Young Adult
authors with profiles
Ezra Cohen